Apr 7, 2025 | Defective Medical Device, Defective Product, Medical News, PowerPort Injuries, Product Liability
The Bard PowerPort, an implantable port catheter designed for patients requiring frequent or long-term intravenous treatments, has recently come under scrutiny due to reports of device failures leading to serious injuries. Patients and their families have initiated...
Nov 11, 2024 | Defective Medical Device, Defective Product, Personal Injury, Product Liability
The PowerPort, manufactured by Bard, a subsidiary of Becton Dickinson (BD), is a medical device designed to provide patients with reliable access to their veins for regular treatments. Such treatments include chemotherapy, IV medication, blood transfusions, and more....
Aug 20, 2024 | Defective Drugs, Defective Medical Device, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab-trbw) is a breakthrough medication used to treat thyroid eye disease (TED), a rare condition that causes inflammation and bulging of the eyes. Tepezza was approved by the U.S. Food and Drug Administration (FDA) in January 2020 and has been...
Aug 8, 2024 | Defective Medical Device, Defective Product, Medical News, Product Liability
Bard PowerPort devices, used in medical treatments requiring frequent injections or infusions, have been the subject of increasing scrutiny due to reports of severe injuries and complications. As a result, many patients and their families are considering legal action...
Jul 29, 2024 | Defective Medical Device, Defective Product, Mass Tort News, Product Liability, Safety
In recent years, there has been a surge in lawsuits against medical device manufacturers, and one of the most notable examples is the litigation involving Bard PowerPort. Bard PowerPort, a medical device designed to facilitate the administration of intravenous fluids,...
